JAFCO

  • News
  • Company
    • Message from the President
    • Corporate Information
    • History
    • Purpose/Mission/Values
    • Sustainability
    • Corporate Governance
    • Access
  • IR
    • IR News
    • IR Library
    • Financial Information
    • Shareholders Information
    • IR Calendar
    • Sustainability
    • To shareholders and investors
    • Share Price Information
    • Analyst Report
  • Contact
  • Recruitment
  • JP
  • Portfolio
  • Partners
  • Investment
    • Our Stance
    • Venture Investment
    • Buyout Investment
    • Fund
  • Support
  • & JAFCO POST
  • JA
  • EN

& JAFCO POST

  1. TOP
  2. & JAFCO POST
  3. Bio
Startup from University of Tokyo Aims to Revolutionize Cell Therapy Accessibility with Mass Production Technology
Dec 20, 2023
Interviews with Entrepreneurs
Startup from University of Tokyo Aims to Revolutionize Cell Therapy Accessibility with Mass Production Technology
  • Bio
Kitasato University's First R&D Drug Venture: Young CEO and Honorary Professor Pursue New Naturally-Derived Drug
Oct 26, 2023
Interviews with Portfolio Companies
Kitasato University's First R&D Drug Venture: Young CEO and Honorary Professor Pursue New Naturally-Derived Drug
  • Academia-Industry Collaboration and Life Sciences
  • Bio
  • Medical
Transforming the medical field with a cell analysis platform. Listening to the voices of users and taking on the challenge of putting cutting-edge technology to practical use.
Jun 14, 2023
Interviews with Entrepreneurs
Transforming the medical field with a cell analysis platform. Listening to the voices of users and taking on the challenge of putting cutting-edge technology to practical use.
  • AI
  • Bio
Global expansion of synthetic biology solutions Prevail over common sense in medicine and biomanufacturing with genome engineering technology
Apr 7, 2023
Interviews with Entrepreneurs
Global expansion of synthetic biology solutions Prevail over common sense in medicine and biomanufacturing with genome engineering technology
  • Bio
  • Industry/Academia/Life Science
Create innovation in medicine and drug discovery. I want to save patients around the world with cutting-edge microbiomes
Jan 19, 2023
Interviews with Entrepreneurs
Create innovation in medicine and drug discovery. I want to save patients around the world with cutting-edge microbiomes
  • Bio
  • Industry/Academia/Life Science
Brain health care becomes a commonplace society. I want to solve the world's aging issues with technology originating in Japan
Dec 2, 2021
Interviews with Entrepreneurs
Brain health care becomes a commonplace society. I want to solve the world's aging issues with technology originating in Japan
  • AI
  • Bio
  • Health care
Revolutionizing the world of "drug discovery" A bio-venture that makes full use of AI and robots
Sep 23, 2021
Interviews with Entrepreneurs
Revolutionizing the world of "drug discovery" A bio-venture that makes full use of AI and robots
  • Bio
  • Industry/Academia/Life Science
  • Medical
"Synthesis" of DNA and "editing" of genome The future that bio-startups from Kobe University are looking at
Dec 10, 2020
Interviews with Entrepreneurs
"Synthesis" of DNA and "editing" of genome The future that bio-startups from Kobe University are looking at
  • Bio
  • Industry/Academia/Life Science
  • Medical
PREV
  1. 1
NEXT
Category
  • Knowledge
  • EIR Program
  • JAFCO
  • Dialogues with Portfolio Companies
  • 50th Anniversary
  • Interviews with Portfolio Companies
  • Interviews with Entrepreneurs
  • notice
  • Entrepreneur talk
  • Entrepreneurial failure studies
  • News
  • Investee support
  • Open innovation
  • Research
  • Investee dialogue
  • global investment
Tag
  • & JAFCO meet up Innovators
  • &JAFCO POST
  • Academia-Industry Collaboration and Life Sciences
  • agritech
  • AI
  • Babson College
  • Back office support
  • BACK TO THE VENTURE
  • Bio
  • Capital Alliance
  • deep tech
  • DX
  • EC
  • education
  • energy
  • Energy
  • Entertainment
  • esports
  • Event report
  • Female entrepreneur
  • femtech
  • financial services tech
  • Fintech
  • First Leap
  • Food Tech
  • game
  • global
  • Health care
  • HR support
  • HR Tech
  • Icon Ventures
  • Industry/Academia/Life Science
  • IPO
  • IT
  • JAFCO Asia
  • JAFCO Research Institute
  • legal tech
  • market place
  • Marketing
  • Marketing and sales support
  • Marketplace
  • media
  • Medical
  • Mobility
  • Press release
  • retail
  • robot
  • SaaS
  • sales tech
  • Seed early
  • TOKIO terrace
Page Top
  • Portfolio
  • Your Partners
  • Our Investment
    • Our Stance
    • Venture Investment
    • Buyout Investment
    • Funds
  • Our Support
  • & JAFCO POST
  • News
    • Press Release
    • News
  • Company
    • Message from the President
    • Corporate Information
    • History
    • Purpose/Mission/Values
    • Sustainability
    • Corporate Governance
    • Access
  • IR Information
    • IR News
    • IR Library
    • Financial Information
    • Shareholders Information
    • IR Calendar
    • Sustainability
    • To shareholders and investors
    • Share Price Information
    • Analyst Report
  • Contact
  • Recruitment
e-shishobako
  • Facebook
  • X
  • YouTube
  • Adoption of “Japan’s Stewardship Code”
  • Points to Consider Concerning Contributions to Funds
  • Protection of Personal Information
  • Website Terms of Use
  • Site map
Financial Instrument Firm: Director-General of Kanto Local Finance Bureau (Kinsho) No. 1693
Member of Japan Investment Advisers Association, Type II Financial Instruments Firms Association
Copyright © JAFCO Group Co., Ltd. All Rights Reserved.
JAFCO